1. |
尹周一, 王夢圓, 游偉程, 等. 2022美國癌癥統計報告解讀及中美癌癥流行情況對比. 腫瘤綜合治療電子雜志, 2022, 8(2): 54-63.
|
2. |
Lyman GH. Venous thromboembolism in the patient with cancer: focus on burden of disease and benefits of thromboprophylaxis. Cancer, 2011, 117(7): 1334-1349.
|
3. |
Khorana AA. Venous thromboembolism and prognosis in cancer. Thromb Res, 2010, 125(6): 490-493.
|
4. |
于歡, 張嵐, 孔亞男, 等. 肺癌術后患者使用間歇充氣加壓裝置預防靜脈血栓栓塞癥依從性的質性研究. 錦州醫科大學學報, 2023, 44(1): 70-74.
|
5. |
崔超毅, 張榮, 宋菊民, 等. 腹部外科病人術后癥狀性靜脈血栓栓塞癥中心臨床流行病學研究. 中國實用外科雜志, 2020, 40(5): 547-550, 556.
|
6. |
王敬瀚. ROC曲線在臨床醫學診斷實驗中的應用. 中華高血壓雜志, 2008, 16(2): 175-177.
|
7. |
Gerotziafas GT, Taher A, Abdel-Razeq H, et al. A predictive score for thrombosis associated with breast, colorectal, lung, or ovarian cancer: the prospective COMPASS-cancer-associated thrombosis study. Oncologist, 2017, 22(10): 1222-1231.
|
8. |
李積鳳, 楊媛華. 《肺血栓栓塞癥診治與預防指南》—關于靜脈血栓栓塞癥預防的推薦意見. 中國醫刊, 2018, 53(10): 1078-1082.
|
9. |
Key NS, Khorana AA, Kuderer NM, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol, 2020, 38(5): 496-520.
|
10. |
Cronin M, Dengler N, Krauss ES, et al. Completion of the updated Caprini risk assessment model (2013 Version). Clin Appl Thromb Hemost, 2019, 25: 1076029619838052.
|
11. |
Gerotziafas GT, Mahé I, Lefkou E, et al. Overview of risk assessment models for venous thromboembolism in ambulatory patients with cancer. Thromb Res, 2020, 191 Suppl 1: S50-S57.
|
12. |
Khorana AA, Kuderer NM, Culakova E, et al. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood, 2008, 111(10): 4902-4907.
|
13. |
Barbar S, Noventa F, Rossetto V, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the padua prediction score. J Thromb Haemost, 2010, 8(11): 2450-2457.
|
14. |
Wells PS, Anderson DR, Bormanis J, et al. Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Lancet, 1997, 350(9094): 1795-1798.
|
15. |
楊淼, 謝晶, 馬亮英, 等. 3種血栓風險評估表對老年下肢骨折病人術后并發深靜脈血栓的預測價值. 實用老年醫學, 2021, 35(9): 914-917.
|
16. |
Dozio E, Vettoretti S, Caldiroli L, et al. Advanced glycation end products (AGE) and soluble forms of AGE receptor: emerging role as mortality risk factors in CKD. Biomedicines, 2020, 8(12): 638.
|
17. |
Autar R. Nursing assessment of clients at risk of deep vein thrombosis (DVT): the Autar DVT scale. J Adv Nurs, 1996, 23(4): 763-770.
|
18. |
陳曉潔, 汪永堅, 俞菁菁, 等. Autar量表在預防乳腺癌術后并發下肢深靜脈血栓形成應用的效果觀察. 護理研究, 2016, 30(19): 2414-2415.
|
19. |
詹愛丁, 蔣國洪. 改良Autar量表在婦科腫瘤術后深靜脈血栓預防中的應用. 全科護理, 2017, 15(25): 3142-3143.
|